Bayer is pressing ... given alongside aspirin plus a P2Y12 inhibitor – at one year. Once again, there was no significant observed increase in bleeding with asundexian at any dose or compared ...
As low-dose prophylactic aspirin therapy becomes common among older people, potential risks that are associated with such treatment assume increasing importance. In particular, some clinicians are ...
Bayer (BAYZF) stock in focus as the company inks a licensing deal with Puhe BioPharma to develop a cancer candidate targeting ...
Paracetamol, aspirin and ibuprofen are among the most widely used. While they are all effective for pain relief, they each ...
The German firm licensed a PRMT5 inhibitor that’s now in Phase 1 testing. Elsewhere, GSK is testing an intriguing hypothesis ...
Bayer AG’s shares dropped after the German conglomerate was ordered by a jury in the US state of Georgia to pay almost $2.1 billion to a plaintiff who claimed its Roundup weedkiller caused ...
A Georgia jury found pharmaceutical and agricultural products giant Bayer liable for more than $2 billion in damages to a plaintiff who argued that Roundup weed killer caused his cancer ...
A jury in Georgia has ordered Monsanto parent Bayer to pay nearly $2.1 billion in damages to a man who says the company’s Roundup weed killer caused his cancer, according to attorneys ...
In a statement, Bayer said that after reviewing the data for eliapixant (formerly BAY1817080 ) it had concluded that "the overall benefit no long outweighs the risk" in the drug's four target ...
Instead of blaming downsizing, companies are publicly calling their former employees "low performers" to excuse their termination. A group of business and HR experts discussed the cruel reason ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback